IMMray™ PanCan-d detects 98% of pancreatic cancers
in retrospective study with 1400 blood samples
Find the answers of a generation in a single drop of blood
We went through the work of a generation of researchers, mapping the immune system response to cancer, molecule by molecule. We pinned down a combination of 25 clinically relevant markers for successful early stage diagnosis of pancreatic cancer. Using antibodies on a single multiplex chip, we measure them all in one go. All you have to do is to apply a drop of blood.
Immunovia AB first trading day on Nasdaq First North